Chemerin as a marker of subclinical cardiac involvement in psoriatic patients

Aksu F., Caliskan M., Keles N., Toprak A. E. , Uzuncakmak T. K. , Kostek O., ...More

CARDIOLOGY JOURNAL, vol.24, no.3, pp.276-283, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.5603/cj.a2017.0031
  • Title of Journal : CARDIOLOGY JOURNAL
  • Page Numbers: pp.276-283


Background: Chemerin has been associated with psoriasis and inflammation, but there are no studies demonstrating an association between chemerin and subclinical cardiac involvement in psoriatic patients. Therefore, the present study aimed to evaluate whether psoriatic patients with increased epicardial fat tissue, impaired flow-mediated dilatation, and diastolic dysfunction have higher serum chemerin levels than a healthy control group.